Multiple Assemblies exist for SMTL entry 8g6t
Bromodomain of CBP liganded with inhibitor iCBP2; X-RAY DIFFRACTION 1.75 Å

	SMTL ID 8g6t.1 Ligands (6S)-1-(3,4-dibromophenyl)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}piperidin-2-one Polypeptides CREB-binding protein Oligo-state monomer
	SMTL ID 8g6t.2 Ligands (6S)-1-(3,4-dibromophenyl)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}piperidin-2-one Polypeptides CREB-binding protein Oligo-state monomer
	SMTL ID 8g6t.3 Ligands (6S)-1-(3,4-dibromophenyl)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}piperidin-2-one; NICKEL (II) ION Polypeptides CREB-binding protein Oligo-state monomer
	SMTL ID 8g6t.4 Ligands (6S)-1-(3,4-dibromophenyl)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}piperidin-2-one; NICKEL (II) ION Polypeptides CREB-binding protein Oligo-state monomer